|
Sign In to gain access to subscriptions and/or personal tools.
|
Resolving the mysteries of the renin-angiotensin system in diabetes
Atsuhiro Ichihara
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
References
- Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. N Engl J Med 1985; 312:1412-17.[Abstract]
- Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.[Abstract/Free Full Text]
- Brenner BM, Cooper ME, deZeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.[Abstract/Free Full Text]
- Veniant M., Menard J., Bruneval P., Morley S., Gonzales MF, Mullins J. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 1996;98:1966-70.[Web of Science][Medline]
[Order article via Infotrieve]
- Kim S., Hosoi M., Nakajima K., Yamamoto K. Immunological evidence that kidney is primary source of circulating inactive prorenin in rats. Am J Physiol Renal Physiol 1991; 260:E526-E536.
- Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109:1417-27.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Suzuki F., Hayakawa M., Nakagawa T. et al. Human prorenin has `gate and handle` regions for its non-proteolytic activation. J Biol Chem 2003;278:22217-22.[Abstract/Free Full Text]
- Ichihara A., Kaneshiro Y., Suzuki F. Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension. Expert Opin Investig Drugs 2006;15:1137-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ichihara A., Kaneshiro Y., Takemitsu T. et al. Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006;47:894-900.[Abstract/Free Full Text]
- Ichihara A., Kaneshiro Y., Takemitsu T. et al. Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006;17:2495-503.[Abstract/Free Full Text]
- Ichihara A., Suzuki F., Nakagawa T. et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 2006;17:1950-61.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 4,
250-251 (2006)
DOI: 10.1177/14703203060070040201

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|